Patents by Inventor Yaxian WANG

Yaxian WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11663159
    Abstract: A method, apparatus, system, and computer program code for policy-based enforcement in a data virtualization system is provided. Responsive to receiving a query, a computer identifies a virtual object among a set of connected objects that is represented by a set of data assets and their hierarchical relationships. The virtual object corresponds to a subset of the data assets. The computer identifies a subset of objects according to a cumulative transitive closure of the virtual object over the set of connected objects. The computer identifies a set of policies for the subset of objects. For each object in the subset of objects, the computer determines an intermediate decision according to set of policies, whereby a set of intermediate decisions is formed. The computer deterministically reconciles the set of intermediate decisions to generate a resolved decision. The computer provides access to the queried virtual objects based on the resolved decision.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: May 30, 2023
    Assignee: International Business Machines Corporation
    Inventors: Maxim Neaga, Roger C. Raphael, Shantanu Sadanand Mundkur, Hebert Walter Pereyra, Yaxian Wang
  • Publication number: 20230067938
    Abstract: A method, apparatus, system, and computer program code for policy-based enforcement in a data virtualization system is provided. Responsive to receiving a query, a computer identifies a virtual object among a set of connected objects that is represented by a set of data assets and their hierarchical relationships. The virtual object corresponds to a subset of the data assets. The computer identifies a subset of objects according to a cumulative transitive closure of the virtual object over the set of connected objects. The computer identifies a set of policies for the subset of objects. For each object in the subset of objects, the computer determines an intermediate decision according to set of policies, whereby a set of intermediate decisions is formed. The computer deterministically reconciles the set of intermediate decisions to generate a resolved decision. The computer provides access to the queried virtual objects based on the resolved decision.
    Type: Application
    Filed: August 31, 2021
    Publication date: March 2, 2023
    Inventors: Maxim Neaga, Roger C. Raphael, Shantanu Sadanand Mundkur, Hebert Walter Pereyra, Yaxian Wang
  • Patent number: 10639399
    Abstract: Provided is a use of one or more MicroRNA genes selected from miRNAs of Family Let-7, miR-21 or miR-222 in the construction of tissue engineered nerves and in the repair of peripheral nerve defects. An outer and/or internal surface or pores of a tissue engineered nerve graft are coated or adsorbed with polymeric nanomicrospheres carrying a Let-7 family miRNA inhibitor, miR-21, or miR-222, or a mimetic thereof, wherein the polymeric material is composed of biocompatible fibronectin and heparin. The regeneration of peripheral nerves and the construction of tissue engineered nerves are promoted by regulating the expression of MicroRNA genes which can effectively promote the proliferation of primary Schwann cells cultured in vitro and have an anti-apoptotic effect on neuronal cells. In-vivo test proves that bridging of the tissue engineered nerve graft can facilitate the regeneration of peripheral nerves, thus being useful in the treatment of peripheral nerve injury.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: May 5, 2020
    Assignee: NANTONG UNIVERSITY
    Inventors: Xiaosong Gu, Fei Ding, Xin Tang, Yumin Yang, Bin Yu, Shiying Li, Songlin Zhou, Luzhong Zhang, Yaxian Wang, Yun Gu, Hualin Sun
  • Publication number: 20190111179
    Abstract: Provided is a use of one or more MicroRNA genes selected from miRNAs of Family Let-7, miR-21 or miR-222 in the construction of tissue engineered nerves and in the repair of peripheral nerve defects. An outer and/or internal surface or pores of a tissue engineered nerve graft are coated or adsorbed with polymeric nanomicrospheres carrying a Let-7 family miRNA inhibitor, miR-21, or miR-222, or a mimetic thereof, wherein the polymeric material is composed of biocompatible fibronectin and heparin. The regeneration of peripheral nerves and the construction of tissue engineered nerves are promoted by regulating the expression of MicroRNA genes which can effectively promote the proliferation of primary Schwann cells cultured in vitro and have an anti-apoptotic effect on neuronal cells. In-vivo test proves that bridging of the tissue engineered nerve graft can facilitate the regeneration of peripheral nerves, thus being useful in the treatment of peripheral nerve injury.
    Type: Application
    Filed: April 5, 2017
    Publication date: April 18, 2019
    Inventors: Xiaosong GU, Fei DING, Xin TANG, Yumin YANG, Bin YU, Shiying LI, Songlin ZHOU, Luzhong ZHANG, Yaxian WANG, Yun GU, Hualin SUN